Document is current
Any future updates will be listed below
-
Authors
Toth, Damon J. A.
Sheets, Theresa R.
Beams, Alexander B.
Ahmed, Sharia M.
Seegert, Nathan
Love, Jay
Keegan, Lindsay T.
Samore, Matthew H.
-
Funding
Funding for this research was provided by:
Pfizer
Centers for Disease Control and Prevention (75D30121F00003)
Centers for Disease Control and Prevention (75D30121F00003)
Centers for Disease Control and Prevention (75D30121F00003)
Centers for Disease Control and Prevention (75D30121F00003)
Centers for Disease Control and Prevention (75D30121F00003)
Centers for Disease Control and Prevention (75D30121F00003)
Centers for Disease Control and Prevention (75D30121F00003)
State of Utah (AR3473)
State of Utah (AR3473)
- License Information
-
More Information
Article History
Received: 2 May 2024
Accepted: 7 October 2024
First Online: 25 October 2024
Declarations
:
: The University of Utah Institutional Review Board reviewed the surveillance project that produced the data analyzed in this manuscript and determined it as non-research public health surveillance, waived the requirement for documented consent, and determined that use of these data for analysis to understand the dynamics of SARS-CoV-2 transmission was exempt from further review (IRB_00132598). Individuals were informed of the project procedures and that participation was voluntary. Participants provided their agreement to participate and were given the chance to opt out of having their data used for future research. The data were analyzed anonymously for this manuscript.
: Not applicable.
: D.T. reports receiving grants from Pfizer, Inc. A.B. reports receiving graduate student funding from bioMérieux. All other authors declare that they have no competing interests.
